ASPARAGINE-RICH METASTATIC NICHES DRIVE PROSTATE CANCER ORGANOTROPISM BY ENABLING TRANSLATIONAL REWIRING TOWARD N-GLYCOSYLATED PROTEINS
Erica PranziniiD, Luigi IppolitoiD, Marta IozzoiD, S. Romagnoli, Greta Bertoli, Giacomo VendittiiD, Matteo LulliiD, Alice SantiiD, Giuseppina ComitoiD, Simone PolvaniiD, Tiziano LottiniiD, Matteo BenelliiD, Domenica ScumaciiD, Paola ChiarugiiD, Elisa GiannoniiD
Abstract
Metastatic disease is the leading cause of mortality in prostate cancer (PC), with bone as the preferential site of dissemination and the lung frequently affected secondarily. Metabolic interactions between disseminated tumor cells and tissue-specific microenvironments play a key role in shaping site-specific metastatic patterns. In particular, the availability of certain metabolites before, during, and after the establishment of overt metastases represents a critical determinant of colonization. Here we show that asparagine (Asn) is selectively enriched in bone and lung microenvironments and supports PC metastatic colonization. Dietary Asn restriction selectively impairs bone and lung metastases in vivo, without affecting metastatic burden in other organs. Mechanistically, disseminated PC cells arriving at Asn-rich niches rely on extracellular Asn due to decreased asparagine synthetase (ASNS) expression enabling the activation of mTORC1-dependent translational program. Elevated Asn availability selectively promotes the synthesis of Asn-rich proteins enriched in N-glycosylation motifs (Asn-X-Ser/Thr), leading to enhanced global protein N-glycosylation during early metastatic colonization. This metabolic adaptation facilitates cell-cell interactions and promotes adhesion to bone- and lung-specific extracellular matrices. Among the N-glycosylated proteins induced by Asn, CD44 emerges as a central effector of PC bone metastases. Extracellular Asn shortening, genetic or pharmacological disruption N-glycosylation, or silencing of CD44 abolish the pro-metastatic advantage conferred by Asn. Together, these findings identify environmental Asn as a niche-specific metabolic cue that drives PC organotropism by rewiring translation toward proteins enriched in N-glycosylation sites, thereby enhancing adhesive interactions and revealing metabolic vulnerabilities that could be therapeutically exploited to interfere with earliest steps of metastatic colonization in PC.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bonemicroenvironment signatures
S. Karkampouna, M. R. De Filippo, … M. Kruithof-de Julio·bioRxiv·Apr 3, 2020
- Human bone marrow adipocytes drive prostate cancer bone metastasis progression via lipid-mediated induction of Angiopoietin-like 4
Marine Hernandez, Sauyeun Shin, … Camille Attané·bioRxiv·Jul 21, 2026
- Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition
S.-H. Lin, Y.-C. Lee, … L.-y. Yu-Lee·bioRxiv·Nov 8, 2021
- Neutrophils orchestrate pre-metastatic immunosuppressive bone marrow remodeling during prostate cancer metastasis
Yingkui Tang, Xuan Zhou, … Shancheng Ren·bioRxiv·Oct 9, 2026
- Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
G. Zhao, G. Forn-Cuni, … E. B. Snaar·bioRxiv·Aug 14, 2023
- Platelet TSP-1 Controls Prostate Cancer-Induced Osteoclast Differentiation and Bone Marrow-Derived Cell Mobilization through TGFβ-1
B. A. Kerr, K. S. Harris, … T. V. Byzova·bioRxiv·Feb 11, 2020